Noninvasive White Blood Cell Monitoring Startup Leuko Raises $1.8 Million Seed Round
- Pegasus Tech Ventures
- Jul 23, 2019
- 1 min read
Leuko Labs was our 2018 #StartupWorldCup Grand Finale Champion who have announced yesterday that they have raised $1.8 million seed round. Startup World Cup
Leuko Labs is a MIT-born technology startup developing the first non-invasive white blood cell monitoring device.
They raised $1.8 million in seed financing from Pegasus Tech Ventures, Good Growth Capital, Nina Capital, and others. Read more here.
Retro Bowl captures the spirit of classic football games by providing easy controls, strategic depth, and a rewarding progression system.
Leuko’s technology 1v1 LOL aims to help clinicians track immune health without the need for frequent blood draws—reducing discomfort for patients while enabling more continuous, real-time monitoring
As the 2018 Startup World Cup Grand Finale Champion, Leuko Labs has demonstrated not only early innovation potential but also strong validation from investors. Its MIT origins and focus on developing the first non-invasive white blood cell monitoring device position the startup at the intersection of cutting-edge technology and critical medical need. The backing from reputable venture firms such as Pegasus Tech Ventures, Geometry Dash Good Growth Capital, and Nina Capital signals confidence in Leuko Labs’ vision and its ability to transform patient monitoring by making it safer, more accessible, and more comfortable.
Snow Rider is a high-speed arcade game that tests your reflexes as you glide through thrilling icy landscapes.
Your car may be tiny, but your responsibility is huge in Eggy Car. Protecting that egg feels like guarding a treasure. It’s a funny yet serious mission that never gets old.